EGFR targeted nanoparticle feasibility study (2016–2017)

Grant type:
Samyang Biopharmaceuticals Corporation
Researchers:
  • Senior Group Leader
    Australian Institute for Bioengineering and Nanotechnology
  • NHMRC Career Dev Fel & Group Ldr
    Centre for Advanced Imaging
    Affiliate PRF & Group Leader
    Australian Institute for Bioengineering and Nanotechnology
  • Senior Research Fellow
    Australian Institute for Bioengineering and Nanotechnology
Funded by:
Samyang Biopharmaceuticals Corporation